Davita Healthcare Partners Inc (DVA) Stock Price, Quote & News

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 720-631-2100

Website: www.davita.com

Address:

2000 16th Street, Denver, United States

Noname2022 Jan. 14 at 2:50 AM

$DVA $CRMD Are you going to do the right thing and start using Defencath?

2 · Reply

Noname2022 Jan. 13 at 3:54 PM

$AKBA $DVA Men lie, women lie, numbers don’t

0 · Reply

Noname2022 Jan. 13 at 2:59 PM

$AKBA $DVA Village wide at Davita since Nov 2025 Where are the sales?! Oh that’s right, provider driven demand..

1 · Reply

JosephSmith835 Jan. 12 at 5:35 PM

$TMO $DVA Healthcare stability

0 · Reply

Noname2022 Jan. 12 at 5:19 PM

$AKBA $DVA Amazing access! Where’s the Q4 LDO revenue? “On August 18, DaVita, Inc. initiated an operational pilot at over 100 dialysis clinics. Akebia expects the pilot to complete in November at which point Vafseo is expected to be widely available to DaVita patients.” “increasing total prescribing access across our customer base by the end of Q3 to 60,000 patients. We continue to expect this number to grow to 275,000 patients by the end of the year.” https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-reports-third-quarter-2025-financial-results

1 · Reply

Noname2022 Jan. 12 at 3:18 PM

$AKBA $DVA “Q4 2024 Vafseo net product revenue… will be in the range of $5-$6 million” I’m shocked…

0 · Reply

SuperGreenToday Jan. 12 at 1:37 PM

$DVA Share Price: $111.43 Contract Selected: Apr 17, 2026 $110 Calls Buy Zone: $7.14 – $8.82 Target Zone: $12.03 – $14.70 Potential Upside: 59% ROI Time to Expiration: 94 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Noname2022 Jan. 11 at 11:28 PM

$CRMD $DVA Hey ”Safety Expert ” : ”DefenCath® demonstrated a 72% reduction in CRBSI and 70% reduction in hospitalizations secondary to CRBSI” https://cormedix.com/cormedix-therapeutics-announces-positive-data-from-ongoing-real-world-evidence-study-of-defencath/

1 · Reply

Noname2022 Jan. 11 at 12:42 AM

$CRMD $AKBA $FMS $DVA

2 · Reply

DollarFlipper Jan. 10 at 11:57 AM

$MOH $DVA

0 · Reply

DaVita Names New Leaders to Accelerate Care Transformation

Dec 3, 2025, 9:30 AM EST - 5 weeks ago

DaVita: More Volatile But Better Upside Than Fresenius

Nov 17, 2025, 1:57 PM EST - 2 months ago

DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 14, 2025, 4:16 PM EST - 2 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 4, 2025, 8:00 AM EST - 2 months ago

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Oct 29, 2025, 7:46 PM EDT - 2 months ago

DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 5:32 PM EDT - 2 months ago

DaVita misses quarterly profit estimates on rising costs, lower volumes

Oct 29, 2025, 4:05 PM EDT - 2 months ago

DaVita Inc. 3rd Quarter 2025 Results

Oct 20, 2025, 8:00 AM EDT - 3 months ago

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

Oct 13, 2025, 2:00 PM EDT - 3 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Aug 27, 2025, 8:00 AM EDT - 5 months ago

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Aug 21, 2025, 5:59 PM EDT - 5 months ago

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 20, 2025, 9:36 AM EDT - 5 months ago

DaVita: Aggressive Buybacks Despite Rising Cost Of Debt

Aug 5, 2025, 10:02 PM EDT - 5 months ago

DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 5:15 PM EDT - 5 months ago

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 4:05 PM EDT - 5 months ago

DaVita Inc. 2nd Quarter 2025 Results

Jul 17, 2025, 5:37 PM EDT - 6 months ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jun 2, 2025, 12:15 PM EDT - 8 months ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

May 30, 2025, 2:35 PM EDT - 8 months ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 27, 2025, 11:30 AM EDT - 8 months ago

DaVita: International Expansion And Buybacks Will Boost Returns

May 20, 2025, 4:42 PM EDT - 8 months ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 9:05 AM EDT - 8 months ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 8:51 AM EDT - 8 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 12, 2025, 9:41 PM EDT - 8 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 5:37 PM EDT - 8 months ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 4:51 PM EDT - 8 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:05 PM EDT - 8 months ago

DaVita Inc. 1st Quarter 2025 Results

Apr 30, 2025, 11:00 AM EDT - 9 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 14, 2025, 7:35 AM EDT - 9 months ago

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:33 AM EDT - 9 months ago

Dialysis firm DaVita hit by ransomware attack

Mar 31, 2025, 7:35 AM EDT - 10 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

Mar 6, 2025, 10:00 AM EST - 11 months ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Feb 27, 2025, 9:00 AM EST - 11 months ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 19, 2025, 8:05 PM EST - 11 months ago

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 14, 2025, 1:01 PM EST - 11 months ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 8:16 AM EST - 11 months ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 13, 2025, 8:19 PM EST - 11 months ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:13 PM EST - 11 months ago

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 6:07 PM EST - 11 months ago

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 4:05 PM EST - 11 months ago

DaVita Inc. 4th Quarter 2024 Results

Jan 30, 2025, 11:55 AM EST - 1 year ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 28, 2025, 2:39 PM EST - 1 year ago

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

CI CVS HCA UHS

Jan 15, 2025, 9:05 AM EST - 1 year ago

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

Jan 9, 2025, 11:00 AM EST - 1 year ago

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

Nov 14, 2024, 2:19 PM EST - 1 year ago

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 12, 2024, 9:05 AM EST - 1 year ago

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

Nov 8, 2024, 4:33 PM EST - 1 year ago

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

Oct 29, 2024, 9:27 PM EDT - 1 year ago

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 4:23 PM EDT - 1 year ago

DaVita misses third-quarter profit estimates on higher costs

Oct 29, 2024, 4:05 PM EDT - 1 year ago

DaVita Inc. 3rd Quarter 2024 Results

Noname2022 Jan. 14 at 2:50 AM

$DVA $CRMD Are you going to do the right thing and start using Defencath?

2 · Reply

Noname2022 Jan. 13 at 3:54 PM

$AKBA $DVA Men lie, women lie, numbers don’t

0 · Reply

Noname2022 Jan. 13 at 2:59 PM

$AKBA $DVA Village wide at Davita since Nov 2025 Where are the sales?! Oh that’s right, provider driven demand..

1 · Reply

JosephSmith835 Jan. 12 at 5:35 PM

$TMO $DVA Healthcare stability

0 · Reply

Noname2022 Jan. 12 at 5:19 PM

1 · Reply

Noname2022 Jan. 12 at 3:18 PM

$AKBA $DVA “Q4 2024 Vafseo net product revenue… will be in the range of $5-$6 million” I’m shocked…

0 · Reply

SuperGreenToday Jan. 12 at 1:37 PM

0 · Reply

Noname2022 Jan. 11 at 11:28 PM

1 · Reply

Noname2022 Jan. 11 at 12:42 AM

$CRMD $AKBA $FMS $DVA

2 · Reply

DollarFlipper Jan. 10 at 11:57 AM

$MOH $DVA

0 · Reply

TSLA_S3XY Jan. 10 at 2:43 AM

$CRMD We're down more than $DVA In Last Year. Maybe They Were Right.

1 · Reply

oooooopppllll Jan. 9 at 4:11 PM

$DVA This stock really sucks rn lol downtrend gonna continue ... forever ?!

0 · Reply

REZZAYO Jan. 9 at 2:45 PM

$CRMD Guidance 2026 FCF per Share $1.19 - $1.44 2027 FCF per Share $0.77 - $1.04 Cash per Share $1.90 Debt per Share -$1.92 Excluding: 1- MA Contract 2- Base Utilisation Growth 3- $DVA Contract 4- off label Revenues for P3 Rezzayo 5- off label Revenues for P3 TPN 6- off label Revenues for P3 Pediatric 7- Kidney Care Access Protection Act potential

0 · Reply

Noname2022 Jan. 9 at 12:10 PM

$CRMD $FMS $DVA Used ChatGPT to summarize a new CRBSI study comparing catheter types shows catheter choice alone doesn’t solve infections, which keeps lock solutions relevant. https://academic.oup.com/ckj/article/19/1/sfaf392/8381221?login=false#google_vignette

0 · Reply

Noname2022 Jan. 8 at 4:29 PM

$CRMD $AKBA $FMS $DVA

1 · Reply

Noname2022 Jan. 4 at 11:39 PM

$AKBA $DVA Access is “better than ever.” Which is great, because now there’s nowhere left to hide if sales don’t show up.

2 · Reply

Noname2022 Jan. 4 at 9:39 PM

$CRMD $AKBA $DVA $FMS Dr. Pfaffle, Cormedix cofounder

4 · Reply

Noname2022 Jan. 2 at 7:20 PM

$CRMD $AKBA $FMS $DVA new 2026 rates https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ESRDpayment/Downloads/Drugs-and-Biologicals-Eligible-for-TDAPA.pdf

2 · Reply

Noname2022 Jan. 1 at 10:49 PM

$DVA Not using Defencath, which reduces hospitalizations and infections by 70%! Flu shots, yada yada yada When are you going to take CBRSI’s, the 2nd leading cause of death amongst dialysis patients, more seriously?! What do you say to the families when you could have done better? Only major dialysis clinic NOT using…

0 · Reply

Noname2022 Dec. 31 at 3:34 PM

$AKBA $DVA

1 · Reply

Noname2022 Dec. 30 at 3:51 AM

$CRMD $FMS $DVA Defencath available almost everywhere but NOT at Davita https://evtoday.com/news/cormedix-defencath-evaluated-to-prevent-catheter-related-bloodstream-infections-in-hemodialysis

2 · Reply

Gencooliveoil Dec. 28 at 8:38 PM

$FMS $CRMD $DVA

0 · Reply

Market Cap	7.77B
Revenue (ttm)	12.82B
Net Income (ttm)	936.34M
EPS (ttm)	N/A
PE Ratio	11.49
Forward PE	8.65
Profit Margin	7.31%
Debt to Equity Ratio	-33.86

Volume	1,085,300
Avg Vol	905,500
Day's Range	N/A - N/A
Shares Out	70.60M
Stochastic %K	2%
Beta	0.99
Analysts	Sell
Price Target	$141.00